background image

Clinical Trials In Maryland

Discover hundreds of clinical trials in Maryland.
Search clinical trials in Maryland by city, condition or phase.

e.g. Respiratory Diseases
Maryland•Healthy volunteers: No

A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia

Recruiting
PHASE2

Sponsor:

MeiraGTx, LLC

Location:

Baltimore, Gilbert, Duarte, Miamishow 11 more

Code:

NCT05926765

Conditions

Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AAV2-hAQP1 Concentration 1

AAV2-hAQP1 Concentration 2

Placebo

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Recruiting
PHASE2
PHASE3

Sponsor:

Biomed Industries, Inc.

Location:

Bethesda, Baltimore, Los Angeles, Orangeshow 27 more

Code:

NCT04452565

Conditions

Coronavirus Infection

Severe Acute Respiratory Infection

Severe Acute Respiratory Syndrome Coronavirus 2

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Drug: NA-831

NA-831 and Atazanavir

NA-831and Dexamethasone

Atazanavir and Dexamethasone

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

Recruiting
PHASE3

Sponsor:

Icahn School of Medicine at Mount Sinai

Location:

Bethesda, Baltimore, Baltimore, Little Rockshow 46 more

Code:

NCT04045665

Conditions

Atrial Fibrillation

Stroke

Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Antiplatelet-only strategy

Oral Anticoagulant plus background antiplatelet therapy

GammaPod Dose Escalation Radiation for Early Stage Breast Cancer

Recruiting

Sponsor:

University of Maryland, Baltimore

Location:

Glen Burnie, Columbia, Bel Air, Baltimore

Code:

NCT04234386

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 45+

Healthy Volunteers: Not accepted

Interventions

GammaPod Radiation

Recruiting

Sponsor:

0

Eligibility Criteria

Sex:

Age: 0 - 70+

Healthy Volunteers: Not accepted

Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency

Recruiting
PHASE2

Sponsor:

Dana-Farber Cancer Institute

Location:

Baltimore, Boston, Boston

Code:

NCT03716739

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Testosterone Cypionate 100 MG/ML

Placebo

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Recruiting
PHASE1
PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Bethesda

Code:

NCT05531786

Conditions

Graft vs Host Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pacritinib

Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations

Recruiting
PHASE3

Sponsor:

AstraZeneca

Location:

Towson, Birmingham, Decatur, Sheffieldshow 76 more

Code:

NCT06040086

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

Placebo

Tozorakimab

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study

Recruiting
PHASE2

Sponsor:

NRG Oncology

Location:

Glen Burnie, Columbia, Baltimore, Birminghamshow 147 more

Code:

NCT05327686

Conditions

Metastatic Renal Cell Carcinoma

Stage III Renal Cell Cancer AJCC v8

Stage IV Renal Cell Cancer AJCC v8

Unresectable Renal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Avelumab

Axitinib

Cabozantinib

Ipilimumab

Lenvatinib

DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)

Recruiting
PHASE1
PHASE2

Sponsor:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Location:

Baltimore

Code:

NCT06027086

Conditions

Fibrolamellar Hepatocellular Carcinoma

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Durvalumab

DRP-104

Popular cities in Maryland